Jaivinder Yadav1, Sanjeev Nanda1, Deepak Sharma1. 1. Department of Paediatrics, Pt. B. D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India.
Abstract
OBJECTIVES: The aim of this study was to ascertain the correlation between various opportunistic infections and complications in human immunodeficiency virus (HIV)-1-infected children and the immune status of these patients, evaluated by absolute cluster of differentiation 4 (CD4) count and CD4 percentage. METHODS: This study was conducted from January 2009 to June 2010 at the Antiretroviral Treatment Centre of the Pt. B.D. Sharma Post Graduate Institute of Medical Sciences, a tertiary care hospital in Rohtak, Haryana, in northern India. A total of 20 HIV-1-infected children aged 4-57 months were studied. Demographic and baseline investigations were performed prior to the start of highly active antiretroviral therapy (HAART). A fixed-dose combination of HAART was given based on the patient's weight. Baseline investigations were repeated after six months of HAART. RESULTS: There was a significant increase in the patients' haemoglobin, weight, height and CD4 count after six months of HAART. Significant improvements (P <0.05) were also noted in the patients' immune status, graded according to the World Health Organization. CONCLUSION: This study observed that the severity and frequency of opportunistic complications in paediatric patients with HIV-1 increased with a fall in the CD4 count. The treatment of opportunistic infections, along with antiretroviral therapy, may lead to both clinical and immunological recovery as well as a decreased incidence of future opportunistic infections. The CD4 count may give treating physicians an initial idea about the immune status of each child and could also be used as a biological marker of HAART efficacy. Patient compliance must be ensured during HAART as this is a key factor in improving outcomes.
OBJECTIVES: The aim of this study was to ascertain the correlation between various opportunistic infections and complications in human immunodeficiency virus (HIV)-1-infectedchildren and the immune status of these patients, evaluated by absolute cluster of differentiation 4 (CD4) count and CD4 percentage. METHODS: This study was conducted from January 2009 to June 2010 at the Antiretroviral Treatment Centre of the Pt. B.D. Sharma Post Graduate Institute of Medical Sciences, a tertiary care hospital in Rohtak, Haryana, in northern India. A total of 20 HIV-1-infectedchildren aged 4-57 months were studied. Demographic and baseline investigations were performed prior to the start of highly active antiretroviral therapy (HAART). A fixed-dose combination of HAART was given based on the patient's weight. Baseline investigations were repeated after six months of HAART. RESULTS: There was a significant increase in the patients' haemoglobin, weight, height and CD4 count after six months of HAART. Significant improvements (P <0.05) were also noted in the patients' immune status, graded according to the World Health Organization. CONCLUSION: This study observed that the severity and frequency of opportunistic complications in paediatric patients with HIV-1 increased with a fall in the CD4 count. The treatment of opportunistic infections, along with antiretroviral therapy, may lead to both clinical and immunological recovery as well as a decreased incidence of future opportunistic infections. The CD4 count may give treating physicians an initial idea about the immune status of each child and could also be used as a biological marker of HAART efficacy. Patient compliance must be ensured during HAART as this is a key factor in improving outcomes.
Entities:
Keywords:
AIDS; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Highly Active Antiretroviral Therapy; India
Authors: Valsan Philip Verghese; Thomas Cherian; Anil J Cherian; P George Babu; T Jacob John; Chellam Kirubakaran; P Raghupathy Journal: Indian Pediatr Date: 2002-01 Impact factor: 1.411
Authors: Miriam K Laufer; Joep J G van Oosterhout; M Arantza Perez; Joseph Kanyanganlika; Terrie E Taylor; Christopher V Plowe; Stephen M Graham Journal: Pediatr Infect Dis J Date: 2006-07 Impact factor: 2.129
Authors: B Ledergerber; M Egger; V Erard; R Weber; B Hirschel; H Furrer; M Battegay; P Vernazza; E Bernasconi; M Opravil; D Kaufmann; P Sudre; P Francioli; A Telenti Journal: JAMA Date: 1999-12-15 Impact factor: 56.272
Authors: Purnima Madhivanan; S N Mothi; N Kumarasamy; T Yepthomi; C Venkatesan; John S Lambert; Suniti Solomon Journal: Indian J Pediatr Date: 2003-08 Impact factor: 5.319